Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Genincode Share News (GENI)
GENI Share
Price
GENI Share
News
GENI Share
Chat
GENI Share
Trades
GENI
Live RNS
GENI Share
Charts
GENI Level 2
Console
GENI Live
Share Price
GENI Broker
Ratings
GENI Directors
Deals
GENI Financial
Diary
GENI
Fundamentals
GENI Short
Positions
GENI
Media
GENI Company
Research
GENI Company
Timeline
Share Price Information for Genincode (GENI)
Last checked at -
Last checked at 
Intraday Genincode Share Chart
Genincode News
GENinCode inks collaboration with largest US medical school
(Sharecast News) - Cardiovascular genetics company GENinCode announced a collaboration with the Indiana University School of Medicine (IU) on Wednesda...
TRADING UPDATES: Hyve exits Russia; Genel revenue rises in 2021
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
GENinCode enters cholesterol collaboration with Cumbria health network
(Sharecast News) - Cardiovascular genetics company GENinCode announced a collaboration with the Academic Health Science Network for the North East and...
IN BRIEF: GENinCode Lipid inCode test sees strong results in NHS probe
IN BRIEF: GENinCode Lipid inCode test sees strong results in NHS probe
GENinCode reports success in NHS trial of cholesterol test
(Sharecast News) - Predictive genetics technology company GENinCode announced on Tuesday the successful completion of its NHS clinical study, and posi...
IN BRIEF: GENinCode FDA presubmission for cardiovascular disease test
IN BRIEF: GENinCode FDA presubmission for cardiovascular disease test
EXECUTIVE CHANGES: SIMEC and Feedback tap new chief financial officers
EXECUTIVE CHANGES: SIMEC and Feedback tap new chief financial officers
TRADING UPDATES: Raft of London-listed firms raise 2021 outlook
TRADING UPDATES: Raft of London-listed firms raise 2021 outlook
Follow the stocks
